MICHAEL BRADSHAW: Open Payments
NPI 1104311539 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,008 in 250 payments from 20 companies in 2025. Trend: 2023 $2,954 · 2024 $2,187 · 2025 $4,008
Food & beverage: $3,879Education: $129
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 26 | $498 |
| E.R. Squibb & Sons, L.L.C. | 23 | $413 |
| Teva Pharmaceuticals USA, Inc. | 27 | $413 |
| Otsuka America Pharmaceutical, Inc. | 21 | $410 |
| ABBVIE INC. | 26 | $401 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $300 |
| Janssen Pharmaceuticals, Inc | 13 | $270 |
| Alkermes, Inc. | 17 | $221 |
| Supernus Pharmaceuticals, Inc. | 22 | $219 |
| Axsome Therapeutics, Inc. | 11 | $169 |
Products named: REXULTI, HETLIOZ, COBENFY, VRAYLAR, CAPLYTA, ARISTADA, Qelbree, SPRAVATO.
Industry payments across NC — which companies pay providers there.
